|
EPIX, News out!
Stock exploded from .30 to 1.80 last week on news that the FDA has approved Vasovist Injection (gadofosveset trisodium), the lead product for Epix Pharmaceuticals. This is the first contrast imaging agent approved to be used on patients undergoing MRA (magnetic resonance angiography), according to the FDA. An MRA is a minimally invasive scan for examining blood vessels and uses MRI technology. Vasovist is designed to help doctors see possible blood vessel problems more easily on the scan.
|
Linear Mode
